<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>NEOBENZ(R) MICRO BENZOYL PEROXIDE WASH, 7%- benzoyl peroxide lotion </strong><br>SkinMedica Pharmaceuticals, Inc., Carlsbad, CA 92010<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<span class="Bold">NeoBenz</span><span>® </span><span class="Italics">Micro</span><br>(benzoyl peroxide cream)<br><br><span class="Bold">NeoBenz</span><span>® </span><span class="Italics">Micro </span>SD<br>(benzoyl peroxide cream)<br><br><span class="Bold">NeoBenz</span><span>® </span><span class="Italics">Micro </span>Wash<br>(benzoyl peroxide)<br><br><br><span class="Bold">Rx ONLY. <br>FOR EXTERNAL USE ONLY. </span><span class="Italics"><span class="Bold"><span class="Bold"><span class="Italics"><span class="Italics"></span></span></span></span></span>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>I. DESCRIPTION</h1>
<span>NeoBenz® <span class="Italics">Micro </span>3.5%
and 5.5% creams, </span><span>NeoBenz</span><span>® <span class="Italics">Micro </span>SD 5.5% single dose cream and NeoBenz® <span class="Italics">Micro
</span>Wash 7% are topical preparations containing benzoyl peroxide as the active
ingredient incorporated into patented porous microspheres (</span><span class="Bold">MICROSPONGE</span><span>®*
delivery system) composed of methyl methacrylate/glycol dimethacrylate
crosspolymer. This polymeric system has been shown to provide gradual release
of active ingredient into the skin<span class="Sup">1</span> and absorb natural skin oils<span class="Sup">2</span>.
Ingredients for all cream and SD strengths include: water, glycerin, ethylhexyl
palmitate, sorbitol, cetyl alcohol, glyceryl ditaurate, stealryl alcohol,
magnesium aluminum silicate, methyl methacrylate/glycol dimethacrylate
crosspolymer, silica, citric acid, xanthan gum, methylparaben, sodium </span><span>citrate, </span><span>propyIparaben, polyacrylamide, C13-14 isoparaffin, laureth-7, sodium
lauryl sulfate. Ingredients for the Wash include citric acid, cocamidopropyl
betaine, cocamine oxide, disodium laureth sulfosuccinate, edetate disodium,
fragrance, glycerin, hydrogenated castor oil, hypromellose, magnesium aluminum
silicate, methyl methacrylate/Glycol dimethacrylate crosspolymer,
methylparaben, PEG-150 pentaerythrityl tetrastearate (and) PEG-6
caprylic/capric glycerides, PEG-40 hydrogenated castor oil, poloxamer 182,
purified water and xanthan gum.<br><br></span><span>Benzoyl peroxide is
an oxidizing agent that possesses antibacterial properties and is classified as
a keratolytic. Benzoyl peroxide (C<span class="Sub">14</span>H<span class="Sub">10</span>O<span class="Sub">4</span>) is represented by the following
structure:<br><br></span><div class="Figure"><img alt="Benzoyl-Peroxide-Structural-Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=375bf717-5d70-457e-8b74-1f66f4f08b79&amp;name=Benzoyl-Peroxide-Structural-Formula.jpg"></div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>II. CLINICAL PHARMACOLOGY</h1>
<span>The exact method of
action of benzoyl peroxide in <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span> is not known. Benzoyl peroxide is
an antibacterial agent with demonstrated activity against <span class="Italics">Propionibacterium
<span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acnes</span>. </span>This action, combined with the mild keratolytic effect of benzoyl
peroxide is believed to be responsible for its usefulness in <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span>. Benzoyl </span><span>peroxide </span><span>is absorbed by the skin where </span><span>it </span><span>is metabolized to benzoic acid and </span><span>excreted as benzoate in the urine. </span>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>III. INDICATIONS AND USAGE</h1>
<span>NeoBenz® </span><span class="Italics">Micro, </span><span>NeoBenz® </span><span class="Italics">Micro</span> SD and <span>NeoBenz® </span><span class="Italics">Micro</span> Wash are indicated for use in the topical treatment of mild to moderated <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>.<span></span><br>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>IV. CONTRAINDICATIONS</h1>
<span>NeoBenz® </span><span class="Italics">Micro, </span><span>NeoBenz® </span><span class="Italics">Micro</span> SD and <span>NeoBenz® </span><span class="Italics">Micro</span> Wash <span>should not be used in
patients who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to benzoyl peroxide or to any of the
other ingredients in the products.</span>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="S1"></a><a name="section-6"></a><p></p>
<h1>V. WARNINGS</h1>
<span>When using this
product, avoid unnecessary sun exposure and use a sunscreen.</span>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1>VI. PRECAUTIONS</h1>
<span>(</span><a href="#S1">SEE WARNINGS</a><span>)<br><br></span><span class="Bold">General</span><span>– For
external use only. Avoid contact with eyes and mucous membranes. If severe
irritation develops, discontinue use and institute appropriate therapy.</span>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-8"></a><p></p>
<span class="Bold">Information for
Patients:</span><span> Avoid contact with eyes, eyelids, lips and mucous membranes. If
accidental contact occurs, rinse with water. AVOID CONTACT WITH HAIR, FABRICS
OR CARPETING AS BENZOYL PEROXIDE WILL CAUSE BLEACHING OR DISCOLORATION. If </span><span>excessive </span><span>irritation develops, discontinue use and consult your physician.</span>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-9"></a><p></p>
<span class="Bold">Carcinogenesis,
Mutagenesis, Impairment of Fertility:</span><span> Based upon all available evidence,
benzoyl </span><span>peroxide </span><span>is not considered to be a carcinogen. However, data from a study using mice
known to be highly susceptible to cancer suggest that benzoyl peroxide acts as
a tumor promoter. The clinical significance of the findings is not known.</span>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-10"></a><p></p>
<span class="Bold">Pregnancy:</span><span> Category C
- Animal </span><span>reproduction </span><span>studies have not been conducted with benzoyl peroxide. It is also not
known whether benzoyl peroxide can cause fetal harm when administered to a
pregnant woman or can affect reproduction capacity. Benzoyl peroxide should be
used by a pregnant woman only if clearly needed.</span>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-11"></a><p></p>
<span class="Bold">Nursing Mothers:</span><span> It
is not known whether this drug is excreted in human milk. Because many drugs
are </span><span>excreted in human milk, caution should be
exercised when benzoyl peroxide is administered to a nursing </span><span>woman.</span>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-12"></a><p></p>
<span class="Bold">Pediatric Use:</span><span> Safety
and effectiveness in children below the age of 12 have not been established.</span>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-13"></a><p></p>
<h1>VII . ADVERSE REACTIONS</h1>
<span>Allergic contact
<span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span> and dryness have been reported with topical benzoyl peroxide
therapy.</span>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-14"></a><p></p>
<h1>VIII. OVERDOSAGE</h1>
<span>If excessive scaling,
<span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> or <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> occurs, the use of these preparations should be discontinued.
To hasten resolution of the adverse effects, cool compresses may be used. After
symptoms and signs subside, a reduced dosage schedule may be cautiously tried if
the reaction is judged to be due to excessive use and not allergenicity.</span>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-15"></a><p></p>
<h1>IX. DOSAGE AND ADMINISTRATION</h1>
<span>NeoBenz® </span><span class="Italics">Micro, </span><span>NeoBenz® </span><span class="Italics">Micro</span> SD and <span>NeoBenz® </span><span class="Italics">Micro</span> Wash <span>should be used once
or twice daily on the affected areas. Frequency of use should be adjusted to
obtain the desired clinical response. If <span>yo</span></span><span>u see medication or white residue on skin after application of<span class="Italics"></span><span><span><span><span></span></span></span><span><span> NeoBenz® </span><span class="Italics">Micro</span> or <span class="Italics"><span></span></span></span></span></span>NeoBenz® <span><span><span><span class="Italics"><span></span><span class="Italics">Micro</span></span></span><span> SD, you are applying too much. Gentle cleansing of the affected areas with a mild cleanser prior to application of NeoBenz® <span><span class="Italics"><span><span class="Italics">Micro</span></span></span> or <span>NeoBenz® </span><span class="Italics"><span><span class="Italics"><span class="Italics"><span class="Italics">Micro</span></span></span></span></span></span></span></span></span> SD may be beneficial. Clinically visible improvement will normally occur by the third week if therapy. Maximum lesion reduction may be expected after approximately eight to twelve weeks for drug use. Continuing use of the drug us normally required to maintain a satisfactory clinical response. <span><span><span><span><span class="Italics"><span><br><br></span></span></span></span></span></span><span class="Bold"><span>NeoBenz® </span><span class="Italics">Micro</span></span><span class="Italics">:  </span>If applying to the entire face, apply a pea-sized amount of <span>NeoBenz® </span><span class="Italics">Micro</span> to one fingertip and dab onto cheeks, forehead and chin. Spread evenly onto entire face. <br><br><span></span><span class="Bold"><span>NeoBenz® </span><span class="Italics">Micro</span> SD</span>:  Firmly squeeze applicator until seal between applicator and sponge has broken. Apply medication by rubbing sponge on small circular motions on affected areas. Dispose of each applicator after single use only. <br><br><span class="Bold"><span>NeoBenz® </span><span class="Italics">Micro</span> Wash</span>: Shake well before using. Wet skin areas to be treated; apply <span>NeoBenz® </span><span class="Italics">Micro</span> Wash by massaging gently into skin for 10-20 seconds, working into a full lather. Rinse thoroughly and pat dry.<span class="Italics"></span><span></span>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-16"></a><p></p>
<h1>X. HOW SUPPLIED</h1>NeoBenz® <span class="Italics">Micro</span> is supplied as follows:<br>SIZE: 45 gram tube<br>NDC NUMBER:<br>(3.5% benzoyl peroxide cream): 67402-020-45<br>(5.5% benzoyl peroxide cream): 67402-021-45<br><br>NeoBenz® <span class="Italics">Micro</span> SD is supplied as follows:<br>SIZE: 1 box of thirty 0.5 gram applicators<br>NDC NUMBER:<br>(5.5% benzoyl peroxide cream): 67402-021-06<br><br>NeoBenz® <span class="Italics">Micro</span> Wash is supplied as follows:<br>SIZE: 180 gram tottle<br>NDC NUMBER:<br>(benzoyl peroxide 7%): 67402-027-17<span><br><br></span>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-17"></a><p></p>
<span>Store between 15<span class="Sup">o</span> - 25<span class="Sup">o</span> C (59<span class="Sup">o</span> - 77<span class="Sup">o</span> F)</span><br>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="section-18"></a><p></p>
<h1>REFERENCES</h1>1. Wester RC, Patel R, Nacht S, Leyden J, Melendres J, Maibach H.
Controlled release of benzoyl peroxide from a porous microsphere
polymeric system can reduce topical irritancy. J. Am. Acad. Dermatol.
1991;24; 720-726. <br>2. Meyer R. Rosen (ed.), Delivery System Handbook for Personal care and Cosmetic Products, 332-352 (2005).</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-19"></a><p></p>Distributed by SkinMedica Pharmaceuticals, Inc., Carlsbad. CA 92010<br><br>Covered by Us Patents: 4,690,825; 5,145,675; 5,879,716; 6,007,364. <br><br>*MICROSPONGE®
is a registered trademark of AMCOL Health and Beauty Solutions, Inc, a
subsidiary of AMCOL International Corporation.<br><br><br>129008 December 2008<br>P7001-03</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-20"></a><p></p>
<h1>NeoBenz Micro Wash, Benzoyl Peroxide 7%</h1>
<div class="Figure"><img alt="NBM-Wash-7-180-01-tottle" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=375bf717-5d70-457e-8b74-1f66f4f08b79&amp;name=NBM-Wash-7-180-01-tottle.jpg"></div>
<div class="Figure"><img alt="NBM-Wash-7-180-02-carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=375bf717-5d70-457e-8b74-1f66f4f08b79&amp;name=NBM-Wash-7-180-02-carton.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NEOBENZ(R) MICRO 		
					BENZOYL PEROXIDE WASH, 7%</strong><br><span class="contentTableReg">benzoyl peroxide, 7% lotion</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:67402-027</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>BENZOYL PEROXIDE</strong> (BENZOYL PEROXIDE) </td>
<td class="formItem">BENZOYL PEROXIDE</td>
<td class="formItem">70 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:67402-027-17</td>
<td class="formItem">180 g in 1 CONTAINER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved other</td>
<td class="formItem"></td>
<td class="formItem">12/15/2008</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>SkinMedica Pharmaceuticals, Inc., Carlsbad, CA 92010
							(124977005)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 7/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>375bf717-5d70-457e-8b74-1f66f4f08b79</div>
<div>Set id: 375bf717-5d70-457e-8b74-1f66f4f08b79</div>
<div>Version: 1</div>
<div>Effective Time: 20090706</div>
</div>
</div> <div class="DistributorName">SkinMedica Pharmaceuticals, Inc., Carlsbad, CA 92010</div></p>
</body></html>
